Latest 8-K filings

Remitly Global announced record second-quarter results, surpassing 10 million active customers and raising its full-year financial outlook.

Onterris, Inc. has implemented a preferred share purchase rights plan, commonly known as a 'poison pill,' to deter hostile takeovers.

Dave Inc. announced robust second quarter 2026 financial results, featuring 30% year-over-year revenue growth to $170.8 million and a significant increase in Adjusted EBITDA, leading the company to raise its full-year 2026 guidance.

Clearway Energy, Inc. announced its second quarter 2026 financial results, highlighting robust operational performance and an accelerating growth program, while adjusting its full-year financial guidance.

Protagonist Therapeutics announced robust second quarter 2026 financial results, highlighting the successful commercial launch of ICOTYDE, priority review for rusfertide, and significant progress across its internal R&D pipeline.

Great Elm Capital Corp. announced its second quarter 2026 financial results, highlighting a 3% quarter-over-quarter increase in Net Asset Value (NAV) to $7.95 per share and a strong liquidity position.

Zevia PBC reported second quarter 2026 results with net sales at the high end of its outlook and adjusted EBITDA exceeding expectations, though the company still posted a net loss.

TaskUs announced its second quarter 2026 results, reporting $308.9 million in service revenue and raising its full-year revenue and Adjusted EBITDA margin guidance.

Energy Recovery, Inc. announced its second quarter 2026 financial results, reporting a 57% decrease in revenue to $12.0 million and a net loss of $3.2 million.

Alpha Teknova announced strong second quarter 2026 financial results, exceeding revenue expectations and raising full-year guidance, driven by 18% revenue growth.

Ginkgo Bioworks announced a 48% revenue decrease in Q2 2026 to $20 million and an increased Adjusted EBITDA loss of $36 million, while also securing new government contracts for autonomous labs.

Sarepta Therapeutics reported Q2 2026 results with $328.7 million in net product revenue and achieved both GAAP and non-GAAP operating profitability, while narrowing full-year revenue guidance.

Deluxe Corporation announced robust second quarter 2026 results, highlighted by significant growth in its Payments and Data segments, increased cash flow, and an improved full-year financial outlook following the Celero acquisition.

AppLovin Corporation announced robust financial results for the second quarter of 2026, showcasing substantial year-over-year growth across key metrics and providing optimistic guidance for the third quarter.

SenesTech announced record Q2 2026 revenue of $770,000, a 56% sequential increase, alongside a company-record 73.6% gross margin, fueled by accelerated e-commerce growth.

Emergent BioSolutions reported Q2 2026 results with increased revenues but a substantial net loss, prompting a restructuring plan aimed at $40 million in annual savings.

The Honest Company announced Q2 2026 results, showcasing significant gross margin expansion and a raised full-year financial outlook, driven by higher-margin growth platforms.

a.k.a. Brands Holding Corp. announced its second quarter 2026 financial results, reporting a slight decrease in net sales but an improvement in net loss and Adjusted EBITDA, while reiterating its full-year outlook.

Inseego Corp. announced its second quarter 2026 financial results, reporting revenue of $44.0 million, exceeding guidance, and achieving Adjusted EBITDA of $0.5 million.

LegalZoom reports Q2 2026 results with 7% revenue growth driven by an 11% increase in subscription revenue, while updating its full-year outlook to reflect industry-wide shifts in customer discovery.

IonQ announced record second quarter 2026 revenues of $80.1 million, a 287% year-over-year increase, and raised its full-year revenue guidance to $280-$290 million following the acquisition of SkyWater Technology.

AmperCap Acquisition Company has amended its Administrative Services Agreement with its sponsor, AmperSPAC LLC, changing the payment schedule for services.

Revolution Medicines announced robust second quarter 2026 results, highlighting U.S. FDA acceptance of its New Drug Application for daraxonrasib and promising clinical data across multiple oncology indications.

Runway Growth Finance Corp. announced its third quarter 2026 regular dividend of $0.33 per share, with specific record and payment dates.

Carlsmed, Inc. announced robust second quarter 2026 financial results, showcasing 57% year-over-year revenue growth and an increase in gross margins, leading to an upward revision of its full-year revenue outlook.

SmartStop Self Storage REIT, Inc. announced robust second quarter 2026 results, marked by significant year-over-year increases in FFO per share and same-store NOI, leading to an upward revision of its full-year guidance.

Pattern Group Inc. announced record second quarter 2026 financial results, with revenue up 47% year-over-year to $877 million, and raised its full-year financial outlook.

Duolingo announced robust second quarter 2026 financial results, showcasing a significant acceleration in Daily Active Users (DAU) growth and reaffirming its full-year financial outlook.

Symbotic Inc. announced robust third-quarter fiscal year 2026 financial results, featuring a 22% year-over-year revenue increase and a significant shift from net loss to net income, alongside the appointment of Stephen G. Pagliuca to its Board of Directors.

Mativ Holdings announced robust second quarter 2026 financial results, showcasing a significant increase in adjusted EBITDA and free cash flow, alongside a return to GAAP profitability.